Abiopharma

🔍 MOULDER LEON O JR (Director)

Company: Zenas BioPharma, Inc. (ZBIO)

Report Date: 2026-04-28

Detailed Transactions and Holdings:

• Acquired 25,000 shares of Common Stock at $18.02 per share (Direct)
  Date: 2026-04-28 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,751,039.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 35,000 shares of Common Stock at $17.62 per share (Direct)
  Date: 2026-04-29 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,786,039.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-28 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 36,928.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-28 | Code: H | shares_owned_after: 423,155.00

Footnotes:

• F1: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $17.87 to $18.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
• F2: Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC ("Tellus") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
• F3: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $17.56 to $17.67, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
• F4: The reporting person is a Trustee of the Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 (the "Trust") and may be deemed to have voting and dispositive power over the shares held by the Trust. The reporting person is the Issuer's chief executive officer and Chairman of its board of directors. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.